Issued Patents All Time
Showing 1–25 of 52 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12391753 | Antigen binding molecule formats | Samuel Davis, Chia-Yang Lin, Eric Smith, Erica Pyles, Michael Rosconi +3 more | 2025-08-19 |
| 12384827 | Chimeric NK receptor and methods for treating cancer | Charles L. Sentman | 2025-08-12 |
| 12331109 | Antigen binding molecule formats | Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith +3 more | 2025-06-17 |
| 12319724 | IL2 agonists and methods of use thereof | Jiaxi WU, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher | 2025-06-03 |
| 12319939 | Carbonyl reductase mutant and its application | Xiuzhen Gao, Qinyuan Ma, Yanmiao Yin, Yanling Zhao, Zhixin Ma | 2025-06-03 |
| 12234286 | Anti-TIGIT antibodies and their use as therapeutics and diagnostics | Liu XUE, Qi Liu, Min Wei, Kang Li | 2025-02-25 |
| 12215148 | Antigen binding molecule formats | Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith +3 more | 2025-02-04 |
| 12215131 | IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof | Jiaxi WU, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher | 2025-02-04 |
| 12180272 | Antigen binding molecule formats | Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith +3 more | 2024-12-31 |
| 12168681 | Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof | Jiaxi WU, Samuel Davis, Nicolin Bloch | 2024-12-17 |
| 12103974 | Anti-OX40 antibodies and methods of use | Ye Liu, Zuobai WANG, Kang Li | 2024-10-01 |
| 12091440 | IL2 and peptide-MHC complex fusion proteins and methods of use thereof | Jiaxi WU, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher | 2024-09-17 |
| 12065492 | Anti-B7-H6 antibody, fusion proteins, and methods of using the same | Charles L. Sentman | 2024-08-20 |
| 11965020 | Antigen binding molecule formats | Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith +3 more | 2024-04-23 |
| 11872248 | Nucleic acids encoding chimeric receptor comprising NKP30 receptor and CD28 and CD3 zeta domains and human T cell containing | Charles L. Sentman | 2024-01-16 |
| 11858976 | Nucleic acid constructs encoding chimeric NK receptor, cells containing, and therapeutic use thereof | Charles L. Sentman | 2024-01-02 |
| 11834485 | IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereof | Jiaxi WU, Samuel Davis, Nicolin Bloch | 2023-12-05 |
| 11744804 | Microcapsule powder stable in gastric acid, method for preparing same, and use thereof | Jiansheng Chen, Bo Zhang, Yaying Hou, Jing Lv | 2023-09-05 |
| 11725034 | IL2 agonists and methods of use thereof | Jiaxi WU, Maria del Pilar MOLINA-PORTELA, Eric Smith, Chia-Yang Lin, Thomas Craig Meagher | 2023-08-15 |
| 11708407 | Antigen binding molecule formats | Erica Pyles, Michael Rosconi, Nina Liu, Supriya Patel, Eric Smith +3 more | 2023-07-25 |
| 11701357 | Treatment of B cell cancers using a combination comprising Btk inhibitors | Nan-Xing Hu, Lai-Xi Wang, Jing Song, Kang Li, Lusong Luo +3 more | 2023-07-18 |
| 11673951 | Anti-PD1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Lanlan Xu, Qi Liu, Hao Peng | 2023-06-13 |
| 11534431 | Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer | Jing Song, Lai-Xi Wang, Kang Li, Lusong Luo, Min Wei +3 more | 2022-12-27 |
| 11518807 | Heavy chain constant regions with reduced binding to Fc gamma receptors | Samuel Davis, Eric Smith, Supriya Patel | 2022-12-06 |
| 11512132 | Anti-PD-L1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Yucheng Li, Zhiying REN, Yanshen KANG | 2022-11-29 |